SCHAMBYE HANS T. (Chief Executive Officer) sold 15.5% of their position (735.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2025ACC: 0000950170-25-094576
DirectorOfficer· Chief Executive Officer
Since Oct 2020
-735.00
Net shares
Net seller
$2.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.36K acquired · 2.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.36K
Price / share
—
Trade value
—
% of position
40.0%
7/3/2025
3.40K→4.76K
Common Stock
Direct
Shares
−735.00
Price / share
$3.38
Trade value
$2.48K
% of position
15.5%
7/3/2025
4.76K→4.02K
Total
Net shares
+625.00
Net value
-$2.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2025 | M · Option Exercise | +1.36K | — | — | 40.0% | 3.40K | 4.76K |
| Common Stock Direct | 7/3/2025 | S · Sale | −735.00 | $3.38 | $2.48K | 15.5% | 4.76K | 4.02K |
| Total | +625.00 | -$2.48K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.36K shares
Shares
−1.36K
Strike price
Held after
4K
Exercisable
—
7/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.36K shares | 7/3/2025 | M · Option Exercise | −1.36K | — | 4K |